These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13107625)

  • 1. The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat.
    SKELTON FR
    Endocrinology; 1953 Nov; 53(5):492-505. PubMed ID: 13107625
    [No Abstract]   [Full Text] [Related]  

  • 2. The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat.
    SALGADO E; SELYE H
    Endocrinology; 1954 Nov; 55(5):550-60. PubMed ID: 13210297
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of thyroidectomy on hypertension, nephrosclerosis and cardiac lesions produced by desoxycorticosterone acetate (DCA) treatment in the rat.
    SALGADO E
    Endocrinology; 1954 Oct; 55(4):377-86. PubMed ID: 13200448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypercorticism].
    LAROCHE C; LEPRAT J
    Actual Biol; 1954; 1():313-80. PubMed ID: 14398504
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of urea on the hypertension and vascular lesions produced in the rat by methylandrostenediol and desoxycorticosterone acetate.
    SKELTON FR
    Lab Invest; 1957; 6(3):266-74. PubMed ID: 13429847
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal factors in the production of experimental renal and cardiovascular disease; synergism between somatotrophic hormone and methylandrostenediol.
    SALGADO E; SELYE H
    J Lab Clin Med; 1955 Feb; 45(2):237-46. PubMed ID: 13233650
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental hypertensive vascular disease in the rat; a histopathologic study of the lesions produced by methylandrostenediol and desoxycorticosterone acetate.
    SKELTON FR
    AMA Arch Pathol; 1955 Aug; 60(2):190-200. PubMed ID: 14397947
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of androstene derivatives on metacorticoid hypertension.
    STURTEVANT FM
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):262-3. PubMed ID: 13121006
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of thyroidectomy associated with cortisone treatment on meta-corticoid hypertension].
    SALGADO E
    Rev Can Biol; 1953 Nov; 12(3):449-51. PubMed ID: 13167757
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of benzedrine on hypertension produced by desoxycorticosterone].
    JASMIN G; GOSSELIN R
    Rev Can Biol; 1953 Nov; 12(3):446-9. PubMed ID: 13167756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention with hypophysectomy of certain lesions produced by overdosage of desoxycorticosterone].
    SALGADO E; SELYE H
    Ann Endocrinol (Paris); 1953; 14(3):366-71. PubMed ID: 13124838
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental hypertension.
    GREEN DM
    Ann Intern Med; 1953 Aug; 39(2):333-44. PubMed ID: 13080891
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin content of systemic blood of rats with desoxycorticosterone and metacorticoid hypertension.
    PRADO JL; PICARELLI ZP; KUPPER R; PRADO ES; VALLE JR
    Circ Res; 1954 Jul; 2(4):359-66. PubMed ID: 13172881
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of indomethacin on desoxycorticosterone acetate-sodium chloride-induced renal lesions in the pregnant rat and her offspring.
    Parks BR; Douglas BH; Weaver MM; Gillespie JE; Davenport WD; Rawson JE
    Dev Pharmacol Ther; 1980; 1(4):229-37. PubMed ID: 7438969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular arteriolar nodules. Their presence in heart, pancreas, and kidneys of patients with malignant nephrosclerosis.
    Hughson MD; Harley RA; Henninger GR
    Arch Pathol Lab Med; 1982 Feb; 106(2):71-4. PubMed ID: 6895829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrotropic effect of methylandrostenediol; experimental studies on intact and castrated rat].
    DE MATTEIS F; GALASSI M; SCARABICCHI S
    Folia Endocrinol Mens Incretologia Incretoterapia; 1954 Jun; 7(3):267-92. PubMed ID: 13200593
    [No Abstract]   [Full Text] [Related]  

  • 17. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess.
    Chu PY; Zatta A; Kiriazis H; Chin-Dusting J; Du XJ; Marshall T; Kaye DM
    Circ Heart Fail; 2011 Sep; 4(5):651-8. PubMed ID: 21685249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, hematological and biochemical study of combined desoxycorticosterone, methylandrostenediol and pregnenolone therapy of a tuberculous patient].
    RUBINO GF; GIULIANO V
    Gazz Med Ital; 1954 Sep; 113(9):269-72. PubMed ID: 13232214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on tissue potassium in experimental myocarditis due to desoxycorticosterone].
    JUSTIN-BESANCON L; RUBENS-DUVAL A; VILLIAUMEY J; MAZARD J; PIGNARD P
    Ann Endocrinol (Paris); 1953; 14(3):405-8. PubMed ID: 13124844
    [No Abstract]   [Full Text] [Related]  

  • 20. [The adrenal cortex and experimental articular lesions].
    JUSTIN-BESANCON L; RUBENS-DUVAL A; VILLIAUMEY J; KAHN J
    Sem Hop; 1953 Jun; 29(40):1987-93. PubMed ID: 13089712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.